🇺🇸 FDA
Patent

US 10308927

Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease

granted A61KA61K2039/523A61K2039/5254

Quick answer

US patent 10308927 (Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease) held by The United States of America, as represented by the Secretary of Homeland Security expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Homeland Security
Grant date
Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K2039/523, A61K2039/5254, A61K2039/5258, A61K39/12